Stockreport

Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows [Reuters]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as Novo Nordisk's diabetes drug Ozempic or weight-loss treatment Wegovy, [Read more]